Previous Article | Next Article 
Molecular and Cellular Biology, October 1999, p. 6833-6844, Vol. 19, No. 10
0270-7306/99/$04.00+0
hnRNP U Inhibits Carboxy-Terminal Domain Phosphorylation by TFIIH
and Represses RNA Polymerase II Elongation
Myung K.
Kim1,* and
Vera M.
Nikodem2
Genetics and Biochemistry Branch, National Institute of
Diabetes and Digestive and Kidney Diseases, and Laboratory of
Molecular Hematology, National Heart, Lung, and Blood
Institute,1 and Mechanisms of Gene
Regulation Section, Genetics and Biochemistry Branch, National
Institute of Diabetes and Digestive and Kidney
Diseases,2 National Institutes of Health,
Bethesda, Maryland 20892
Received 1 June 1999/Accepted 5 July 1999
This study describes a potential new function of hnRNP U as an RNA
polymerase (Pol II) elongation inhibitor. We demonstrated that a
subfraction of human hnRNP U is associated with the Pol II holoenzyme
in vivo and as such recruited to the promoter as part of the
preinitiation complex. hnRNP U, however, appears to dissociate from the
Pol II complex at the early stage of transcription and is therefore
absent from the elongating Pol II complex. When tested in the human
immunodeficiency virus type 1 transcription system, hnRNP U inhibits
elongation rather than initiation of transcription by Pol II. This
inhibition requires the carboxy-terminal domain (CTD) of Pol II. We
showed that hnRNP U can bind TFIIH in vivo under certain conditions and
inhibit TFIIH-mediated CTD phosphorylation in vitro. We find that the
middle domain of hnRNP U is sufficient to mediate its Pol II
association and its inhibition of TFIIH-mediated phosphorylation and
Pol II elongation. The abilities of hnRNP U to inhibit TFIIH-mediated
CTD phosphorylation and its Pol II association are necessary for hnRNP
U to mediate the repression of Pol II elongation. Based on these
observations, we suggest that a subfraction of hnRNP U, as a component
of the Pol II holoenzyme, may downregulate TFIIH-mediated CTD
phosphorylation in the basal transcription machinery and repress Pol II
elongation. With such functions, hnRNP U might provide one of the
mechanisms by which the CTD is maintained in an unphosphorylated state
in the Pol II holoenzyme.
*
Corresponding author. Mailing address: Bldg. 10, Room
7D11, Laboratory of Molecular Hematology, NHLBI, National Institutes of
Health, 9000 Rockville Pike, Bethesda, MD 20892. Phone: (301) 594-2924. Fax: (301) 496-9985. E-mail:
kimm{at}gwgate.nhlbi.nih.gov.
Molecular and Cellular Biology, October 1999, p. 6833-6844, Vol. 19, No. 10
0270-7306/99/$04.00+0
This article has been cited by other articles:
-
Ameyar-Zazoua, M., Souidi, M., Fritsch, L., Robin, P., Thomas, A., Hamiche, A., Percipalle, P., Ait-Si-Ali, S., Harel-Bellan, A.
(2009). Physical and Functional Interaction between Heterochromatin Protein 1{alpha} and the RNA-binding Protein Heterogeneous Nuclear Ribonucleoprotein U. J. Biol. Chem.
284: 27974-27979
[Abstract]
[Full Text]
-
Winteringham, L. N., Endersby, R., Kobelke, S., McCulloch, R. K., Williams, J. H., Stillitano, J., Cornwall, S. M., Ingley, E., Klinken, S. P.
(2006). Myeloid Leukemia Factor 1 Associates with a Novel Heterogeneous Nuclear Ribonucleoprotein U-like Molecule. J. Biol. Chem.
281: 38791-38800
[Abstract]
[Full Text]
-
Jimeno, S., Luna, R., Garcia-Rubio, M., Aguilera, A.
(2006). Tho1, a Novel hnRNP, and Sub2 Provide Alternative Pathways for mRNP Biogenesis in Yeast THO Mutants. Mol. Cell. Biol.
26: 4387-4398
[Abstract]
[Full Text]
-
Liu, Y., Ando, S., Xia, X., Yao, R., Kim, M., Fondell, J., Yen, P. M.
(2005). p62, A TFIIH Subunit, Directly Interacts with Thyroid Hormone Receptor and Enhances T3-Mediated Transcription. Mol. Endocrinol.
19: 879-884
[Abstract]
[Full Text]
-
Alex, D., Lee, K. A. W.
(2005). RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains. Nucleic Acids Res
33: 1323-1331
[Abstract]
[Full Text]
-
Herrmann, F., Bossert, M., Schwander, A., Akgun, E., Fackelmayer, F. O.
(2004). Arginine Methylation of Scaffold Attachment Factor A by Heterogeneous Nuclear Ribonucleoprotein Particle-associated PRMT1. J. Biol. Chem.
279: 48774-48779
[Abstract]
[Full Text]
-
Thomas, D., Blakqori, G., Wagner, V., Banholzer, M., Kessler, N., Elliott, R. M., Haller, O., Weber, F.
(2004). Inhibition of RNA Polymerase II Phosphorylation by a Viral Interferon Antagonist. J. Biol. Chem.
279: 31471-31477
[Abstract]
[Full Text]
-
Howell, M., Borchers, C., Milgram, S. L.
(2004). Heterogeneous Nuclear Ribonuclear Protein U Associates with YAP and Regulates Its Co-activation of Bax Transcription. J. Biol. Chem.
279: 26300-26306
[Abstract]
[Full Text]
-
Villa, A., Santiago, J., Belandia, B., Pascual, A.
(2004). A Response Unit in the First Exon of the {beta}-Amyloid Precursor Protein Gene Containing Thyroid Hormone Receptor and Sp1 Binding Sites Mediates Negative Regulation by 3,5,3'-Triiodothyronine. Mol. Endocrinol.
18: 863-873
[Abstract]
[Full Text]
-
Hayano, T., Yanagida, M., Yamauchi, Y., Shinkawa, T., Isobe, T., Takahashi, N.
(2003). Proteomic Analysis of Human Nop56p-associated Pre-ribosomal Ribonucleoprotein Complexes: POSSIBLE LINK BETWEEN Nop56p AND THE NUCLEOLAR PROTEIN TREACLE RESPONSIBLE FOR TREACHER COLLINS SYNDROME. J. Biol. Chem.
278: 34309-34319
[Abstract]
[Full Text]
-
Carty, S. M., Greenleaf, A. L.
(2002). Hyperphosphorylated C-terminal Repeat Domain-associating Proteins in the Nuclear Proteome Link Transcription to DNA/Chromatin Modification and RNA Processing. Mol. Cell. Proteomics
1: 598-610
[Abstract]
[Full Text]
-
Li, K. K. C., Lee, K. A. W.
(2000). Transcriptional Activation by the Ewing's Sarcoma (EWS) Oncogene Can Be Cis-repressed by the EWS RNA-binding Domain. J. Biol. Chem.
275: 23053-23058
[Abstract]
[Full Text]
-
Bajenova, O. V., Zimmer, R., Stolper, E., Salisbury-Rowswell, J., Nanji, A., Thomas, P.
(2001). Heterogeneous RNA-binding Protein M4 Is a Receptor for Carcinoembryonic Antigen in Kupffer Cells. J. Biol. Chem.
276: 31067-31073
[Abstract]
[Full Text]